Marinus Pharmaceuticals, Inc. (MRNS)
NASDAQ: MRNS · IEX Real-Time Price · USD
1.190
-0.090 (-7.03%)
At close: Jul 2, 2024, 4:00 PM
1.160
-0.030 (-2.52%)
After-hours: Jul 2, 2024, 7:19 PM EDT
Marinus Pharmaceuticals Stock Forecast
MRNS's stock price has decreased by -88.82% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts with 12-month price forecasts for MRNS stock have an average target of 10.86, with a low estimate of 2.00 and a high estimate of 28. The average target predicts an increase of 812.61% from the current stock price of 1.19.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for MRNS stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Buy | 5 | 4 | 2 | 2 | 1 | 1 |
Hold | 1 | 1 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 8 | 8 | 8 | 7 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Truist Securities | Truist Securities | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +740.34% | Jun 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +824.37% | Jun 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +824.37% | May 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $11 | Strong Buy | Maintains | $27 → $11 | +824.37% | May 7, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $25 → $10 | Strong Buy | Maintains | $25 → $10 | +740.34% | Apr 17, 2024 |
Financial Forecast
Revenue This Year
40.13M
from 30.99M
Increased by 29.50%
Revenue Next Year
59.33M
from 40.13M
Increased by 47.84%
EPS This Year
-2.00
from -2.63
EPS Next Year
-1.06
from -2.00
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 56.1M | 94.4M | 167.0M | 310.6M | 530.1M |
Avg | 40.1M | 59.3M | 121.1M | 199.6M | 290.8M |
Low | 33.3M | 36.7M | 58.9M | 103.1M | 191.4M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 80.9% | 135.2% | 181.4% | 156.4% | 165.6% |
Avg | 29.5% | 47.8% | 104.1% | 64.8% | 45.7% |
Low | 7.6% | -8.7% | -0.8% | -14.9% | -4.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.51 | -0.62 | -0.11 | 0.75 | 1.65 |
Avg | -2.00 | -1.06 | -0.36 | 0.23 | 0.73 |
Low | -2.53 | -2.02 | -0.62 | -0.23 | 0.23 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 618.3% |
Avg | - | - | - | - | 218.9% |
Low | - | - | - | - | -1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.